An Observational Study of GIOTRIF (Afatinib) for First Line Therapy in Patients With Advanced Non Small Cell Lung Cancer (NSCLC) Harboring Epidermal Growth Factor Receptor (EGFR)-Mutations. First published 09/11/2026 Last updated 09/11/2026 EU PAS number:EUPAS1000001175 Study Finalised